Greater knowledge of pathogen genomics and their vectors may play a major role in preventing and treating infectious diseases.
Researchers identified early genetic diversification in the Justinianic Plague across Western Europe.
This conference aims to unite investigators studying many diverse aspects of genetic recombination in a range of biological systems, and who use different experimental approaches.
This meeting will bring together researchers applying genomic based techniques to crop improvement and plant molecular breeding experts, along with traditional breeders who are interested in applying these techniques within their crops of interest.
Genomic information would help malaria control programs use quality data sets for regular monitoring of drug resistance, provide evidence for poicy decisions, and manage the spread of resistance.
To prepare for the next EVD outbreak, we advocate the establishment of national and regional hubs of excellence in infectious diseases genomics in regions with a high risk of outbreaks, where untargeted metagenomic sequencing analysis would be done.
The 2019 meeting will address DNA sequence variation and its role in molecular evolution, population genetics and complex diseases, comparative genomics, large-scale studies of gene and protein expression, and genomic approaches to ecological systems. Both technologies and applications will be emphasized. In addition there will be a special session on the ethical, legal and social implications of genome research.
This five-day computational course aims to give molecular microbiologists working with bacterial and eukaryotic pathogens a working knowledge of genomic analysis. The course will take the form of a series of modules covering the fundamental aspects of DNA sequence analysis and exploitation.
Sequence data from whole genomes let researchers track the spread of strains worldwide.
The goal of this Keystone Symposia conference is to bring together those developing and studying genome engineering tools with groups who are applying them to build new disease models, identify disease mechanisms and drug targets, and develop cell-based therapeutics and genetic medicines. In addition to covering engineering of human and animal cells, this conference will also highlight the emerging field of genome engineering to identify new anti-microbial and anti-viral drugs and applications toward next-generation antibiotics.